Indication
Active immunisation of sheep to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 2 and 4.
Loading your page…
Loading your page…
Marketing Authorisation Holder: Mérial
EMA Authorisation: 04/11/2010
INN: inactivated adjuvanted vaccine against bluetongue virus serotype 2 and 4 infections
AI Drug & Interaction Analysis
Free account required
Ask Osler about BTVPUR AlSap 2-4: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.